BlackRock Institutional Trust Company, N.A. - CELL THERAPEUTICS INC ownership

CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 75 filers reported holding CELL THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 34.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CELL THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$14,264,000
+85.0%
4,195,238
+3.9%
0.00%
+100.0%
Q4 2013$7,710,000
+34.9%
4,036,831
+14.5%
0.00%0.0%
Q3 2013$5,714,000
+59.8%
3,525,002
+3.5%
0.00%0.0%
Q2 2013$3,575,0003,405,0740.00%
Other shareholders
CELL THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 400,000$1,360,0000.31%
TFS CAPITAL LLC 1,351,073$4,594,0000.30%
Geduld E E 100,000$340,0000.18%
OXFORD ASSET MANAGEMENT LLP 1,429,215$4,859,0000.14%
EAGLE ASSET MANAGEMENT INC 6,718,484$22,842,0000.13%
First Heartland Consultants, Inc. 74,624$254,0000.12%
WASHINGTON TRUST Co 410,616$1,396,0000.10%
FIRST NEW YORK SECURITIES LLC /NY 50,000$170,0000.08%
Tradeworx Inc. 16,704$57,0000.05%
LMR Partners LLP 103,643$352,0000.05%
View complete list of CELL THERAPEUTICS INC shareholders